Key Takeaways:
- Meiogenix, a biotechnology company focused on precision breeding for crop improvement, has appointed Jacqueline Heard, Ph.D., MBA to its Board of Directors.
- Heard most recently founded and led Enko Chem, and previously held senior roles at Monsanto, Flagship Pioneering, CiBO Technologies, Two Blades Foundation, and Mendel Biotechnology.
- The appointment comes as Meiogenix advances commercialisation and partnership development around its targeted recombination platform.
- Heard joins an existing board that includes Neal Gutterson, Jenny Rooke, Michael Krel, Benoit Barteau, and Ricardo Garcia de Alba.
- No financial terms or structural changes to the company were disclosed alongside the announcement.
Meiogenix Names Jacqueline Heard to Its Board of Directors
Biotechnology company Meiogenix announced on 13 April 2026 the appointment of Jacqueline Heard, Ph.D., MBA to its Board of Directors. The company, based in Research Triangle Park, North Carolina, is focused on precision breeding technologies designed to expand access to natural genetic diversity in crops.
The appointment comes as Meiogenix works to advance commercialisation efforts and build partnerships around its targeted recombination platform.
Heard’s Professional Background
Heard has held a range of senior roles across the agricultural and biotechnology sectors. Most recently, she founded and led Enko Chem, a crop protection company that developed an AI-enabled discovery platform for agricultural chemistries. Prior to that, she held leadership positions at Monsanto, Two Blades Foundation, CiBO Technologies, Flagship Pioneering, and Mendel Biotechnology.
She currently serves on several scientific and industry boards, including Sollum Technologies, and until recently held a board position at the Boyce Thompson Institute at Cornell University.
What the Appointment Is Intended to Address
Ricardo Garcia de Alba, CEO of Meiogenix, described the rationale for the appointment in terms of the company’s current commercial priorities. “Jacqueline’s experience building companies and translating cutting-edge science into real-world agricultural solutions will be invaluable as we advance our precision breeding platform and expand partnerships across the global seed industry,” he said.
Neal Gutterson, chairman of Meiogenix, also commented on the appointment, citing Heard’s combination of scientific background, entrepreneurial track record, and strategic experience in the agricultural sector.
Heard’s Own Statement on Joining Meiogenix
Heard stated that the company’s crop breeding technology has the potential to give breeders access to genetic diversity that has previously been difficult to reach. “I look forward to working with the team to help accelerate the adoption of this powerful technology and deliver new solutions that support global food security and agricultural sustainability,” she said.
About the Meiogenix Platform
Meiogenix describes its core technology as an AI-powered precision breeding system that targets meiotic recombination — the natural process by which genetic material is exchanged during reproduction — to help plant breeders access genomic regions that are typically difficult to work with. The company states the platform can be applied across major crops to accelerate the development of new varieties.
The company has not disclosed specific details about current commercial partnerships or the timeline for product deployment in this announcement.
Current Board Composition
With Heard’s addition, the Meiogenix board now includes Neal Gutterson, Jenny Rooke, Michael Krel, Benoit Barteau, Ricardo Garcia de Alba, and Jacqueline Heard.
